Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PX7X
|
||||
Former ID |
DIB007086
|
||||
Drug Name |
Re-188-P-2045
|
||||
Synonyms |
Neotide; P-2045; RE-P2045; Rhenium 188-P-2045; Rhenium-188-labeled peptide (lung cancer), Antisoma; Rhenium-188-labeled peptide (lung cancer), Bryan Oncor/ Antisoma
|
||||
Indication | Lung cancer [ICD9: 162; ICD10:C33-C34] | Phase 1/2 | [533014] | ||
Company |
Diatide Inc
|
||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 2 | Target Info | Modulator | [533014] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.